To include your compound in the COVID-19 Resource Center, submit it here.

CytoTherapeutics deal

By WIR Staff | Mar 21, 1994 | 8:00 AM GMT

CTII (Providence, R.I.) received an exclusive worldwide license

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE